BAP1 or KDM5C mutations in ccRCC associate with aggressive disease, high Fuhrman grade, and metastatic at presentation (Figure 1), that imply worse prognosis and instantaneous activation of mTOR signaling [117,131]. The gene discussed is KDM5C; the disease is nonpapillary renal cell carcinoma.